January 2008
Archives of Disease in Childhood -- Fetal & Neonatal Edition;Jan2008, Vol. 93 Issue 1, pF78
Academic Journal
Correction notice
The article presents two corrections to the article including the rational management of the patent ductus arteriosus that was published in the previous issue and the sustainable use of continuous positive airway pressure in extremely preterm infants during the first week after delivery that was published in the previous issue.


Related Articles

  • Surgical Ligation of Patent Ductus Arteriosus in Very Low Birth Weight Infants: Is It Safe? Perez, Carlos A.; Bustoroff-Silva, Joaquim M. // American Surgeon;Oct1998, Vol. 64 Issue 10, p1007 

    Evaluates the outcome of a combined medical and surgical treatment of patent ductus arteriosus (PDA) in newborns weighing less than 1500 grams. Patient demographics; Treatment strategies in premature infants with PDA: Evolution of PDA management in premature infants; Surgical complications.

  • Patent ductus arteriosus treatment in preterm infants-time to consider shunt volume? Mcnamara, P J; Jain, A // Journal of Perinatology;Mar2013, Vol. 33 Issue 3, p248 

    A letter to the editor is presented in response to the article "What happens when the patent ductus arteriosus is treated less aggressively in very low birth weight infants?" by Kaempf JW, Wu YX, Kaempf AJ, Kaempf AM, Wang L, Grunkemeier G and colleagues.

  • Treatment of patent ductus arteriosus: indomethacin or ibuprofen? Sekar, K. C.; Corff, K. E. // Journal of Perinatology;May2008 Supplement, Vol. 28, pS60 

    Persistent patent ductus arteriosus (PDA) in preterm infants can result in serious hemodynamic changes causing respiratory, gastrointestinal and renal morbidities if not treated within the first week of life. The treatment options available are a conservative approach, pharmacological treatment...

  • AUTHOR'S REPLY. RAJADURAI, VICTOR SAMUEL // Indian Pediatrics;Jul2014, Vol. 51 Issue 7, p586 

    A response from the authors of the article "Current controversies in the management of patent ductus arteriosus in preterm infants" is presented.

  • Tolerance of intravenous indomethacin treatment for premature infants with patent ductus arteriosus. Walters, Margaret // BMJ: British Medical Journal (International Edition);9/24/88, Vol. 297 Issue 6651, p773 

    Examines the effects of intravenous indomethacin on the treatment of premature infants with patent ductus arteriosus in Great Britain. Contraindication of the treatment procedure; Impairment of the kidney function; Detection of gastrointestinal hemorrhage by nasogastric aspiration.

  • Managing the patent ductus arteriosus: current treatment options. Heuchan, Anne Marie; Clyman, Ronald I. // Archives of Disease in Childhood -- Fetal & Neonatal Edition;Sep2014, Vol. 99 Issue 5, pF431 

    Optimal management of the patent ductus arteriosus (PDA) in the premature infant remains controversial. Despite considerable historical and physiological data indicating that a persistent PDA may be harmful, robust evidence of long-term benefits or harms from treatment is lacking. This has been...

  • Safety and efficacy of ibuprofen versus indomethacin in preterm infants. Lago, Paola // European Journal of Pediatrics;2003, Vol. 162 Issue 1, p63 

    Comments on the safety and efficacy of cyclo-oxygenase blockers in preterm infants with patent ductus arteriosus (PDA) and respiratory distress syndrome (RDS). Examination of a physiological control group of premature infants; Study of the epidemiology of PDA and RDS.

  • Patent Ductus Arteriosus in Premature Neonates. Mezu-Ndubuisi, Olachi; Agarwal, Ghanshyam; Raghavan, Aarti; Pham, Jennifer; Ohler, Kirsten; Maheshwari, Akhil // Drugs;2012, Vol. 72 Issue 7, p907 

    Persistent patency of the ductus arteriosus is a major cause of morbidity and mortality in premature infants. In infants born prior to 28 weeks of gestation, a haemodynamically significant patent ductus arteriosus (PDA) can cause cardiovascular instability, exacerbate respiratory distress...

  • Pautas de atención médica a niños con conducto arterioso, menores de 30 semanas de gestación. Hernando Becerra, Georgina; Bernárdez Zapata, Isabel; Iglesias Leboreiro, José; Patiño Bahena, Emilia Josefina; Rendón Macías, Mario Enrique // Revista Mexicana de Pediatria;Jul/Aug2013, Vol. 80 Issue 4, p131 

    The management of patent ductus arteriosus is still controversial in premature newborns. Objective: To analyze the therapeutic conduct used for the closure of patent ductus arteriosus in premature newborns ≤ 30 weeks of gestation. Methods: A retrospective analysis (2005-2011) we analyzed...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics